择期腹腔镜胆囊切除术后延长住院时间的定义及术前风险评分推导
本研究回顾性分析3个外科中心2015年1月至2020年1月共2166例择期腹腔镜胆囊切除术患者,定义术后住院≥3天为延长住院(PLOS),其发生率为6.6%。PLOS与围术期不良结局强相关,推导的术前模型在衍生和验证队列中AUC分别为0.81和0.80。
要点
- 择期腹腔镜胆囊切除术后住院≥3天定义为延长住院(PLOS),发生率6.6%。
- PLOS患者中86.1%发生围术期不良结局,PLOS与所有不良结局强相关(P<0.001)。
- 术前风险模型对PLOS有良好诊断能力(衍生AUC=0.81,验证AUC=0.80)。
核心结论
- PLOS患者围术期并发症发生率高,依据风险工具进行患者选择有助于改善资源利用和风险分层。
研究设计与样本
- 回顾性收集3个外科中心(1个三级转诊中心和2个卫星单位)2015年1月至2020年1月择期腹腔镜胆囊切除术患者2166例。
主要发现
- 术后住院≥3天对手术相关不良结局诊断能力最佳(AUC=0.87)。
- PLOS发生率为6.6%(144/2166),其中86.1%发生围术期不良结局。
- PLOS与所有不良结局(小计、中转开腹、术中并发症、术后并发症/影像/干预)强相关(P<0.001)。
- 术前模型对PLOS诊断能力:衍生队列AUC=0.81,验证队列AUC=0.80。
关键数值与推荐
- PLOS定义为术后住院≥3天(AUC=0.87)。
- 术前风险模型AUC在衍生队列为0.81,验证队列为0.80。
临床怎么用
- 术前使用风险工具识别PLOS高危患者,可辅助日间手术筛选、资源调配和知情同意。
- 风险工具可能有助于在严格门诊/日间中心选择胆囊切除术候选者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The present study defines prolonged length of stay (PLOS) following elective laparoscopic cholecystectomy (LC) and its relationship with perioperative morbidity. A preoperative risk tool to predict PLOS is derived to inform resource utilization, risk stratification and patient consent. BACKGROUND: Surgical candidates for elective LC are a heterogeneous group at risk of various perioperative adverse outcomes. Preoperative recognition of high-risk patients for PLOS has implications on feasibility for day surgery, resource utilization, preoperative risk stratification, and patient consent. METHODS: Data for all patients who underwent elective LC between January 2015 and January 2020 across 3 surgical centers (1 tertiary referral center and 2 satellite units) in 1 health board were collected retrospectively (n=2166). The optimal cut-off of PLOS as a proxy for operation-related adverse outcomes was found using receiver operating characteristic curves. Multivariate logistic regression was conducted on a derivation subcohort to derive a preoperative model predicting PLOS. Receiver operating characteristic curves were performed to validate the model. Patients were stratified by the risk tool and the risks of PLOS were determined. RESULTS: A LOS of ≥3 days following elective LC demonstrated the best diagnostic ability for operation-related adverse outcomes [area under curve (AUC)=0.87] and defined the PLOS cut-off. The rate of PLOS was 6.6% (144/2166), 86.1% of which had a perioperative adverse outcome. PLOS was strongly associated with all adverse outcomes (subtotal, conversion-to-open, intraoperative complications, postoperative complication/imaging/intervention) ( P <0.001). The preoperative model demonstrated good diagnostic ability for PLOS in the derivation (AUC=0.81) and validation cohorts (AUC=0.80) and stratified patients appropriately. CONCLUSIONS: Morbidity in PLOS patients is significant and pragmatic patient selection in accordance with the risk tool may help centers improve resource utilization, risk stratification, and their consent process. The risk tool may help select candidates for cholecystectomy in a strictly ambulatory/outpatient center.
引用
- Lucocq J, Scollay J, Patil P, et al. Defining Prolonged Length of Stay (PLOS) Following Elective Laparoscopic Cholecystectomy and Derivation of a Preoperative Risk Score to Inform Resource Utilization, Risk Stratification, and Patient Consent. Ann Surg. 2022. PMID: 35801705. doi:10.1097/SLA.0000000000005469
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。